Advertisement
Loading...

Artivion, Inc.

AORTNYSE
Healthcare
Medical - Devices
$22.77
$-0.16(-0.70%)
U.S. Market opens in 37h 50m

Artivion, Inc. Fundamental Analysis

Artivion, Inc. (AORT) shows weak financial fundamentals with a PE ratio of 94.59, profit margin of 2.55%, and ROE of 2.66%. The company generates $0.5B in annual revenue with strong year-over-year growth of 13.59%.

Key Strengths

PEG Ratio0.19
Current Ratio3.28

Areas of Concern

ROE2.66%
Operating Margin7.76%
We analyze AORT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 42.8/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
42.8/100

We analyze AORT's fundamental strength across five key dimensions:

Efficiency Score

Weak

AORT struggles to generate sufficient returns from assets.

ROA > 10%
1.32%

Valuation Score

Moderate

AORT shows balanced valuation metrics.

PE < 25
94.59
PEG Ratio < 2
0.19

Growth Score

Moderate

AORT shows steady but slowing expansion.

Revenue Growth > 5%
13.59%
EPS Growth > 10%
1.69%

Financial Health Score

Excellent

AORT maintains a strong and stable balance sheet.

Debt/Equity < 1
0.57
Current Ratio > 1
3.28

Profitability Score

Moderate

AORT maintains healthy but balanced margins.

ROE > 15%
266.09%
Net Margin ≥ 15%
2.55%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is AORT Expensive or Cheap?

P/E Ratio

AORT trades at 94.59 times earnings. This suggests a premium valuation.

94.59

PEG Ratio

When adjusting for growth, AORT's PEG of 0.19 indicates potential undervaluation.

0.19

Price to Book

The market values Artivion, Inc. at 2.45 times its book value. This may indicate undervaluation.

2.45

EV/EBITDA

Enterprise value stands at 14.76 times EBITDA. This signals the market has high growth expectations.

14.76

How Well Does AORT Make Money?

Net Profit Margin

For every $100 in sales, Artivion, Inc. keeps $2.55 as profit after all expenses.

2.55%

Operating Margin

Core operations generate 7.76 in profit for every $100 in revenue, before interest and taxes.

7.76%

ROE

Management delivers $2.66 in profit for every $100 of shareholder equity.

2.66%

ROA

Artivion, Inc. generates $1.32 in profit for every $100 in assets, demonstrating efficient asset deployment.

1.32%

Following the Money - Real Cash Generation

Operating Cash Flow

Artivion, Inc. produces operating cash flow of $56.79M, showing steady but balanced cash generation.

$56.79M

Free Cash Flow

Artivion, Inc. generates weak or negative free cash flow of $12.96M, restricting financial flexibility.

$12.96M

FCF Per Share

Each share generates $0.27 in free cash annually.

$0.27

FCF Yield

AORT converts 1.15% of its market value into free cash.

1.15%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

94.59

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.19

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.45

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.43

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.57

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.28

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.03

vs 25 benchmark

ROA

Return on assets percentage

0.01

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How AORT Stacks Against Its Sector Peers

MetricAORT ValueSector AveragePerformance
P/E Ratio94.5928.62 Worse (Expensive)
ROE2.66%783.00% Weak
Net Margin2.55%-48181.00% (disorted) Weak
Debt/Equity0.570.39 Weak (High Leverage)
Current Ratio3.284.12 Strong Liquidity
ROA1.32%-21914.00% (disorted) Weak

AORT outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Artivion, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

45.55%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

148.90%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

157.45%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ